Clinical Effectiveness of Liraglutide vs Sitagliptin on Glycemic Control and Body Weight in Patients with Type 2 Diabetes: A Retrospective Assessment in Sweden.

Item

http://www.wikidata.org/entity/Q36989711

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Clinical Effectiveness of Lira ...... spective Assessment in Sweden.

@en

type

Item

label

Clinical Effectiveness of Lira ...... spective Assessment in Sweden.

@en

prefLabel

Clinical Effectiveness of Lira ...... spective Assessment in Sweden.

@en

P1476

Clinical Effectiveness of Lira ...... spective Assessment in Sweden.

@en

P2093

Gunnar Johansson

http://www.w3.org/2001/XMLSchema#string

Helge Gydesen

http://www.w3.org/2001/XMLSchema#string

Leif Jørgensen

http://www.w3.org/2001/XMLSchema#string

Marcus Lind

http://www.w3.org/2001/XMLSchema#string

Mozhgan Dorkhan

http://www.w3.org/2001/XMLSchema#string

Per-Olov Matsson

http://www.w3.org/2001/XMLSchema#string

Ragnar Linder

http://www.w3.org/2001/XMLSchema#string

Sara Larsen

http://www.w3.org/2001/XMLSchema#string

P2860

Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

10-year follow-up of intensive glucose control in type 2 diabetes

Dipeptidyl peptidase-4 inhibitors: clinical data and clinical implications.

Liraglutide is effective in type 2 diabetic patients with sustained endogenous insulin-secreting capacity.

Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)

Automated data extraction--a feasible way to construct patient registers of primary care utilization.

Liraglutide Versus Sitagliptin in a 24-week, Multicenter, Open-label, Randomized, Parallel-group Study in Japanese Type 2 Diabetes Mellitus Patients Responding Inadequately to a Sulfonylurea and/or One or Two Other Oral Antidiabetic Drugs (JDDM 33)

Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis.

Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study.

P2888

s13300-016-0173-z

P304

321-333

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13300-016-0173-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Irene Svenningsson

Uffe Jon Ploug

P577

2016-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27216947

http://www.w3.org/2001/XMLSchema#string

P921

An t-Suain

P932

4900983

http://www.w3.org/2001/XMLSchema#string